Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial
卡博特韦和利匹韦林治疗非洲 HIV 感染:3b 期随机、开放标签、非劣效性 CARES 试验第 96 周结果
期刊:Nature Medicine
影响因子:
doi:10.1038/s41591-025-04041-7
Kityo, Cissy; Mambule, Ivan K; Musaazi, Joseph; Sokhela, Simiso; Mugerwa, Henry; Yawe, Ibrahim; Cresswell, Fiona; Siika, Abraham; Kosgei, Josphat; Shah, Reena; Naidoo, Logashvari; Opiyo, Kimton; Otike, Caroline; Möller, Karlien; Okwero, Max; Wambui, Charity; Van Eygen, Veerle; Mohammed, Perry; Addo Boateng, Fafa; Paton, Nicholas I